Expression Methods is a number one provider of modern cell tradition media, baculovirus molecular reagents and cell strains utilized in superior biological-based therapeutics
BUFFALO GROVE, Unwell. and DAVIS, Calif., Nov. 9, 2022 /PRNewswire/ — ANGUS Chemical Firm (“ANGUS” or “Firm”), a number one international producer and marketer of specialty components for Life Sciences and Industrial markets, right this moment introduced it has acquired Expression Systems, LLC (“Expression Methods”), a number one international producer of cell tradition media and associated services. ANGUS is a portfolio firm of Ardian and Golden Gate Capital.
Based in 1997, Expression Methods is devoted to supplying and servicing the baculovirus expression platform with modern cell tradition media formulations, in addition to cell strains, molecular instruments, reagents and contract providers. Expression Methods operates from a central headquarters in Davis, California, and is cGMP-compliant and ISO 13485 licensed for its manufacturing and analysis actions.
“The acquisition of Expression Methods is a vital step in increasing ANGUS’ management place in Life Sciences past bio buffers into specialty cell tradition media, a strategic adjacency with excessive buyer overlap and complementary product and repair choices,” stated ANGUS President and Chief Govt Officer David Neuberger. “The mix of ANGUS and Expression Methods additional strengthens our potential to ship worth by the constant, high-quality components and providers important to all phases of bioprocessing, from early-stage biologics growth to full-scale business manufacturing.”
Expression Methods is a well-recognized unbiased supplier of specialised cell tradition media and associated merchandise with a sturdy observe file of product high quality and innovation primarily based on proprietary know-how. The corporate focuses on baculovirus expression vector system (BEVS) and has deep experience throughout the method from gene optimization to protein purification. Expression Methods’ merchandise are utilized primarily by structural biology researchers and biologics producers to provide sure drug candidates, protein-based therapies, vaccines and gene therapies effectively and cost-effectively.
“For greater than 20 years, our household and devoted staff have constructed a powerful fame with its clients by leveraging our world-renowned technical experience in media manufacturing and the baculovirus expression platform,” stated Expression Methods President and Chief Govt Officer David Hedin. “Once we seemed forward to the longer term for our firm, it was clear that ANGUS was in the very best place to offer new alternatives to our present and new clients, in addition to our staff. ANGUS will improve our place as a devoted, world-leading vendor targeted on servicing the biologics business segments using the baculovirus expression platform.”
Achelous Companions, LLC served as unique M&A advisor to Expression Methods, LLC on this transaction.
ANGUS is a number one international producer and marketer of specialty components and consumables for biotechnology, pharmaceutical, shopper and industrial purposes. The Firm innovates by its distinctive nitroalkane chemistries, together with its flagship AMP™ (aminomethyl propanol) multifunctional components and TRIS AMINO™ (tromethamine) buffers, that are produced at absolutely built-in, ISO 9001-certified manufacturing amenities in america and Germany. ANGUS serves its international clients by six regional Buyer Software Facilities situated in Chicago, Illinois; Paris, France; São Paulo, Brazil; Singapore; Shanghai, China; and Mumbai, India. The Firm is privately owned by Ardian and Golden Gate Capital, and is headquartered in Buffalo Grove, Illinois. For extra info, go to angus.com.
Comply with ANGUS on Facebook, Twitter, and LinkedIn.
FOR ADDITIONAL INFORMATION
ANGUS Media Relations
Scott C. Johnson
SOURCE ANGUS Chemical Firm